Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
Br J Cancer
Springer Science and Business Media LLC
MetadataShow full item record
Goranova, T., Ennis, D., Piskorz, A., Macintyre, G., Lewsley, L., Stobo, J., Wilson, C., et al. (2017). Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.. Br J Cancer, 116 (10), 1294-1301. https://doi.org/10.1038/bjc.2017.86
BACKGROUND: Investigating tumour evolution and acquired chemotherapy resistance requires analysis of sequential tumour material. We describe the feasibility of obtaining research biopsies in women with relapsed ovarian high-grade serous carcinoma (HGSC). METHODS: Women with relapsed ovarian HGSC underwent either image-guided biopsy or intra-operative biopsy during secondary debulking, and samples were fixed in methanol-based fixative. Tagged-amplicon sequencing was performed on biopsy DNA. RESULTS: We screened 519 patients in order to enrol 220. Two hundred and two patients underwent successful biopsy, 118 of which were image-guided. There were 22 study-related adverse events (AE) in the image-guided biopsies, all grades 1 and 2; pain was the commonest AE. There were pre-specified significant AE in 3/118 biopsies (2.5%). 87% biopsies were fit-for-purpose for genomic analyses. Median DNA yield was 2.87 μg, and was higher in biopsies utilising 14 G or 16 G needles compared to 18 G. TP53 mutations were identified in 94.4% patients. CONCLUSIONS: Obtaining tumour biopsies for research in relapsed HGSC is safe and feasible. Adverse events are rare. The large majority of biopsies yield sufficient DNA for genomic analyses-we recommend use of larger gauge needles and methanol fixation for such biopsies, as DNA yields are higher but with no increase in AEs.
Peritoneum, Omentum, Liver, Lymph Nodes, Humans, Carcinoma, Peritoneal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Lymphatic Metastasis, Pain, Proto-Oncogene Proteins B-raf, DNA, Neoplasm, Feasibility Studies, DNA Mutational Analysis, Adult, Aged, Aged, 80 and over, Middle Aged, Female, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), PTEN Phosphohydrolase, Phosphatidylinositol 3-Kinases, Class I Phosphatidylinositol 3-Kinases, Neoplasm Grading, Image-Guided Biopsy, ErbB Receptors
Cancer Research UK (CRUK-A15973)
Cancer Research UK (CRUK-A15601)
External DOI: https://doi.org/10.1038/bjc.2017.86
This record's URL: https://www.repository.cam.ac.uk/handle/1810/285091
Attribution-NonCommercial-ShareAlike 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-sa/4.0/